$BIO News
Last published 1d ago
- 1d agoBIOUBS Global Healthcare Conference - BIO-RAD LABORATORIES INCEarnings Call TranscriptsAll right. Good morning, everybody. I'm Doug Schenkel. And on behalf of UBS, it is my pleasure to welcome Rup Lakharaju, EVP and Chief Financial Officer of BioRad. Rup, thank you for being here this morning. Thanks for h
- 1w agoBIOBio-Rad Third-Quarter 2026 Earnings Results Conference Call and Webcast - BIO-RAD LABORATORIES INCEarnings Call Transcriptsladies and gentlemen thank you for standing by my name is krista and i will be your operator today at this time i would like to welcome everyone to biorad's third quarter 2026 results conference call and webcast all line
- 1w agoBIOBio-Rad Third-Quarter 2026 Earnings Results Conference Call and Webcast - BIO-RAD LABORATORIES INCEarnings Call Transcriptsladies and gentlemen thank you for standing by my name is krista and i will be your operator today at this time i would like to welcome everyone to biorad's third quarter 2026 results conference call and webcast all line
- 1w agoBIOBIO-RAD LABORATORIES, INC. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
- 1w agoBIOBIO.BBio-Rad to Participate in Fireside Chat During UBS Global Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lakkaraju, will participate in a fireside
- 4w agoBIOBIO.BBio-Rad to Report Third-Quarter 2026 Financial Results on Wednesday, November 4, 2026Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2026 on Wednesday, November 4, 2026,
- 1mo agoBIOBIO.BBERNSTEIN INSIGHTS HEALTHCARE LEADERS AND DISRUPTORS - 3RD ANNUAL HEALTHCARE FORUM - BIO-RAD LABORATORIES INCEarnings Call TranscriptsAll right, shall we? Let's do it. All right. Good morning, everyone. Thanks so much for being here. First fireside of the day, so you guys all get brownie points and as much coffee as you want for being here. For anyone
- 1mo agoBIOBIO.BBio-Rad to Participate in Fireside Chat During Bernstein Insights Healthcare Leaders and Disruptors 3rd Annual ForumBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lakkaraju, will participate in a fireside
- 2mo agoBIOBIO.BBIO-RAD LABORATORIES INC - WELLS FARGO 21ST ANNUAL HEALTHCARE CONFERENCE - BIO-RAD LABORATORIES INCEarnings Call TranscriptsSo, this is the last meeting today for Lifesize Tourism Diagnostics, thanks to everyone for being here. We have Bio-Rad, CFO Rup Lakharaju, thank you for being here, maybe the best place to start 2Q, organic growth minus
- 2mo agoBIOBIO.BWells Fargo 21st Annual Healthcare Conference - BIO-RAD LABORATORIES INCEarnings Call TranscriptsSo, this is the last meeting today for Lifesize Tourism Diagnostics, thanks to everyone for being here. We have Bio-Rad, CFO Rup Lakharaju, thank you for being here, maybe the best place to start 2Q, organic growth minus
- 2mo agoBIOBIO.BBio-Rad to Participate in Fireside Chat During Wells Fargo’s 21st Annual Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that its Chief Financial Officer, Roop K. Lakkaraju, will participate in a fireside
- 3mo agoIMDXBIOIMDX Reports Second Quarter 2026 Results and Timely Progress on FDA Review of GraftAssureDxGlobeNewswireDiscussions with FDA advance toward expected marketing authorization for GraftAssureDxFDA completes current portion of substantive review in a timely mannerFavorable Medicare reimbursement policy issued in July
- 3mo agoBIOBIO.BBio-Rad Second Quarter 2026 Earnings Results Conference Call and Webcast - BIO-RAD LABORATORIES INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone to BioRad's second quarter 2026 results conference call and w
- 3mo agoBIOBIO.BBio-Rad Second Quarter 2026 Earnings Results Conference Call and Webcast - BIO-RAD LABORATORIES INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. My name is Lisa, and I will be your conference operator today. At this time, I would like to welcome everyone to BioRad's second quarter 2026 results conference call and w
- 3mo agoBIOBIO.BBio-Rad Reports Second-Quarter 2026 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2026. Norman Schwartz,
- 3mo agoBIOBIO.BBio-Rad to Report Second-Quarter 2026 Financial Results on Tuesday, August 4, 2026Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2026 on Tuesday, August 4, 2026, following
- 5mo agoBIOBIO.BBio-Rad Laboratories, Inc. at Jefferies Global Healthcare Conference in New York - BIO-RAD LABORATORIES INCEarnings Call TranscriptsGreat. We're going to go ahead and kick it off. I'm Tucker Peterson from the Life Science Team. I'm pleased to have Bayerad with us today. We've got Rup. So maybe just to kick itoff, Rup, we could do a quick State of the
- 6mo agoBIOBio-Rad to Participate in Upcoming Investor ConferencesBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that the company will participate in the following upcoming investor conferences: 2026
- 6mo agoBIOBIO.BBio-Rad First-Quarter 2026 Results Conference Call and Webcast - BIO-RAD LABORATORIES INCEarnings Call TranscriptsLadies and gentlemen, thank you for standing by. My name is Regina, and I will be your conference operator today. At this time, I would like to welcome everyone to BioRads' first quarter 2026 results conference call and
- 6mo agoBIOBio-Rad Reports First-Quarter 2026 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2026. Norman Schwartz,
- 6mo agoBIOBio-Rad to Report First-Quarter 2026 Financial Results on Thursday, April 30, 2026Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2026 on Thursday, April 30, 2026, following
- 9mo agoBIOBIO.BBio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - BIO-RAD LABORATORIES INCEarnings Call TranscriptsGood day, everyone, and welcome to the BioRad fourth quarter and full year 2025 results conference call. At this time, I would like to hand things over to Mr. Edward Chung. Please go ahead, sir. Good afternoon, everyone.
- 9mo agoBIOBIO.BBio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial Results - BIO-RAD LABORATORIES INCEarnings Call TranscriptsGood day, everyone, and welcome to the BioRad fourth quarter and full year 2025 results conference call. At this time, I would like to hand things over to Mr. Edward Chung. Please go ahead, sir. Good afternoon, everyone.
- 9mo agoBIOBio-Rad Reports Fourth-Quarter and Full-Year 2025 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full-year ended December 31, 2025. Norman
- 9mo agoBIOBio-Rad to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 12, 2026Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year 2025 on Thursday, February 12,
- 1y agoBIOBio-Rad Reports Third-Quarter 2025 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the third quarter ended September 30, 2025. "During the third
- 1y agoBIOBio-Rad to Report Third Quarter 2025 Financial Results on Wednesday, October 29, 2025Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the third quarter of 2025 on Wednesday, October 29, 2025,
- 1y agoBIOBio-Rad Laboratories, Inc. (BIO) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)Earnings Call Transcripts
- 1y agoBIOBio-Rad's Management to Participate in Upcoming Investor ConferencesBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that members of the company's executive leadership team will participate in the
- 1y agoBIOBio-Rad to Host Droplet Digital PCR Webinar on Tuesday, August 26, 2025Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, announced today that the company's management will host an informational webinar on Bio-Rad's Droplet
- 1y agoBIOBio-Rad Laboratories, Inc. (BIO) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoBIOBio-Rad Reports Second-Quarter 2025 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the second quarter ended June 30, 2025. Norman Schwartz,
- 1y agoBIOBio-Rad Appoints Rajat Mehta Executive Vice President, Global Commercial OperationsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial
- 1y agoBIOBio-Rad to Report Second Quarter 2025 Financial Results on Thursday, July 31, 2025Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2025 on Thursday, July 31, 2025, following
- 1y agoBIOBio-Rad Expands Droplet Digital PCR Offering Through Strategic Acquisition and Platform RolloutBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced the launch of four new Droplet Digital™ PCR (ddPCR™) platforms. The newly
- 1y agoBIOBio-Rad's Management to Host Investor Meetings During Jefferies Global Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Operating Officer Jon DiVincenzo will host one-on-one
- 1y agoBIOBio-Rad's Management to Participate in Fireside Chat During 2025 RBC Capital Markets Global Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that its Chief Executive Officer Norman Schwartz and Chief Financial Officer Roop K.
- 1y agoBIOBio-Rad Reports First-Quarter 2025 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2025. Norman Schwartz,
- 1y agoBDSXBIOBiodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor typesGlobeNewswireLOUISVILLE, Colo. and HERCULES, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc (NASDAQ:BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE:BIO), a global leader in life science
- 1y agoBIOBio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2025 on Thursday, May 1, 2025, following the
- 1y agoBIOOCXOncocyte Reports Successful 2024; Sets Stage for 2025 CatalystsGlobeNewswireQ4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July 2024Signed strategic partner and investor, Bio-Rad LaboratoriesFully funded clinical kitted product
- 1y agoBIOBio-Rad Reports Fourth-Quarter and Full-Year 2024 Financial ResultsBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced financial results for the fourth quarter and full year ended December 31, 2024. Norman
- 1y agoBIOBio-Rad Offers to Acquire Digital PCR Developer Stilla TechnologiesBusiness WireTransaction To Complement Bio-Rad's Existing Digital PCR Portfolio and Accelerate Development of Next-Generation Digital PCR Solutions Bio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research
- 1y agoBIOOCXOncocyte Prices $29.1 Million Equity OfferingGlobeNewswireProceeds Expected to Fund Transplant Assay Through FDA IVD Clearance and Commercial LaunchStrategic Partner Bio-Rad Invests, Boosts Support for Trial and Commercialization IRVINE, Calif., Feb. 10, 2025 (GLOBE
- 1y agoBIOBio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025Business WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year of 2024 on Thursday, February 13,
- 1y agoBIOLHGeneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic TestsBusiness WireBio-Rad leads investment to support the launch of ColoSense®, a non-invasive colorectal cancer screening test, and advance diagnostic innovations for inflammatory bowel disease Geneoscopy, Inc., a life sciences
- 1y agoBIOBio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz, Chief Operating Officer
- 1y agoBIOBio-Rad's Management to Host Investor Meetings at Citi's 2024 Global Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial
- 2y agoBIOBio-Rad's Management to Participate in Fireside Chat During UBS Global Healthcare ConferenceBusiness WireBio-Rad Laboratories, Inc. (NYSE:BIO), a global leader in life science research and clinical diagnostics products, today announced that the company's Chief Executive Officer Norman Schwartz and Chief Financial Officer
- 2y agoBIOBio-Rad Laboratories, Inc. (BIO) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts